KPIs & Operating Metrics(New)
Growth Metrics

Encompass Health (EHC) EBITDA Margin (2016 - 2026)

Encompass Health (EHC) has disclosed EBITDA Margin for 18 consecutive years, with 3.76% as the latest value for Q1 2026.

  • For Q1 2026, EBITDA Margin fell 974.0% year-over-year to 3.76%; the TTM value through Mar 2026 reached 2.43%, down 1430.0%, while the annual FY2025 figure was 7.38%, 372.0% down from the prior year.
  • EBITDA Margin hit 3.76% in Q1 2026 for Encompass Health, up from 26.89% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 16.21% in Q4 2022 and bottomed at 26.89% in Q4 2025.
  • Average EBITDA Margin over 5 years is 7.09%, with a median of 9.87% recorded in 2023.
  • Year-over-year, EBITDA Margin skyrocketed 529bps in 2023 and then crashed -3858bps in 2025.
  • Encompass Health's EBITDA Margin stood at 16.21% in 2022, then plummeted by -57bps to 7.03% in 2023, then soared by 66bps to 11.69% in 2024, then plummeted by -330bps to 26.89% in 2025, then soared by 114bps to 3.76% in 2026.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 3.76%, 26.89%, and 0.85% for Q1 2026, Q4 2025, and Q3 2025 respectively.